All conditions

YOUR CONDITION, EXPLAINED

Non-Hodgkin's Lymphoma VA disability rating & claim guide

The VA rates Non-Hodgkin's Lymphoma under diagnostic code 7715, in 38 CFR § 4.117 (hemic and lymphatic systems), and the schedule provides a single evaluation under it: 100%.

DC 7715Hemic and Lymphatic SystemsData last updated September 23, 2026

Free · No account needed

Save your Non-Hodgkin's Lymphoma guide

Email yourself this Non-Hodgkin's Lymphoma guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.

A CLEARER PATH FORWARD

Make sense of your next step.

01Understand the rating02Know what to gather03Plan your preparation
Based on 38 CFR Part 4Free condition guideTake it one step at a time

THE ESSENTIALS

How the VA rates Non-Hodgkin's Lymphoma

DC 7715 states one evaluation, 100 percent, and reaches it three ways: active disease, a treatment phase, or the indolent and non-contiguous phase of low grade non-Hodgkin's lymphoma. That third route is the one most likely to be missed, because it assigns a total evaluation to a disease that is being watched rather than treated. The note sets the rest: the 100 percent continues beyond cessation of treatment, and TWO YEARS after that treatment is discontinued — not six months, as the other lymphoma and leukemia codes provide — a mandatory VA examination determines the evaluation. If there has been no recurrence, the rating moves to the residuals.

DC 7715's criterion is a single 100 percent evaluation with three alternatives: when there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL. The third alternative is worth reading twice, because it does not depend on treatment or on symptoms — an indolent, non-contiguous low-grade non-Hodgkin's lymphoma on watchful waiting meets the criterion as written. The note is where the code's timing lives: a 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures; TWO YEARS after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination; any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR 3.105(e); and if there has been no recurrence, rate on residuals under the appropriate diagnostic code(s). Two years is four times the interval DC 7709 (Hodgkin's lymphoma) and DC 7703 (leukemia) provide, and the difference is in the regulation rather than in practice — a claim under this code carries the total rating for two full years past the end of treatment before any examination can change it. After that examination the evaluation is either the total rating continuing because of recurrence, or an evaluation of the residuals under other codes. 38 CFR 4.31 supplies a 0 percent where the requirements for a compensable evaluation under this code are not met.

Diagnostic code
7715
Rating schedule
38 CFR § 4.117
Schedule levels
100%
How does the VA choose a rating level?

There is no higher or lower step inside this code: a rating decision either finds its criteria met or it does not. Where they are not met, 38 CFR § 4.31 assigns a 0% evaluation: service connection granted, at a level that does not pay.

EXPLORE THE PERCENTAGES

Non-Hodgkin's Lymphoma VA rating criteria (DC 7715)

This condition has one published rating level. Read the criteria, then explore the details and monthly pay.

VA RATING100%Non-Hodgkin's Lymphoma

WHAT THIS LEVEL MEANS

Active disease, any treatment phase, or the indolent and non-contiguous phase of low-grade NHL — the last of which requires no treatment at all.

Explore 100% criteria & monthly pay
Non-Hodgkin's Lymphoma: the criteria for each rating, quoted from 38 CFR § 4.117, DC 7715
Rating38 CFR criteria (quoted)In plain English (Vetrify’s summary)Monthly pay, 2026 (single veteran)
100%

“When there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL”

Active disease, any treatment phase, or the indolent and non-contiguous phase of low-grade NHL — the last of which requires no treatment at all.$3,938.58

VA pays on the combined rating, not per condition: each amount is what a veteran with no dependents receives when that percentage is the combined rating, after all separate ratings are combined under 38 CFR 4.25.

These are published rating criteria. Selecting a level does not predict your VA decision.

IN THE REGULATION’S OWN WORDS

What 38 CFR also says about Non-Hodgkin's Lymphoma

The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.

  • “Note: A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals under the appropriate diagnostic code(s)”DC 7715

BUILD YOUR EVIDENCE, ONE PIECE AT A TIME

Evidence for your Non-Hodgkin's Lymphoma claim

A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.

Your evidence checklist

Check off what you’ve gathered. Progress stays on this page until you leave or refresh.

0 of 4 gathered

THE EXAM FORM

Which DBQ is used for Non-Hodgkin's Lymphoma?

VA's page says: “You can use these forms to submit medical evidence from your health care providers.”

Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.

SMALL DETAILS. BETTER PREPARATION.

Preparing your Non-Hodgkin's Lymphoma claim

Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.

Practical tips for your claim4 tips
  • 01

    Write the date treatment stopped into the claim and diary two years from it. That is the earliest the evaluation can change under this code.

  • 02

    If the lymphoma is low grade and being observed rather than treated, make sure the record says indolent and non-contiguous. Those are the criterion's own words.

  • 03

    Use the two years to build the residual claims. The note rates on residuals if there has been no recurrence, and each residual needs evidence under its own code.

  • 04

    Ask that the mandatory examination address recurrence directly, since that is the question the note sends it to answer.

C&P exam pitfalls to keep in mind4 tips
  • 01

    The two-year period treated as six months. Every other malignancy code in this section uses six months; this one says two years, and reading across from a neighbouring code is the easy mistake.

  • 02

    A low-grade lymphoma on watchful waiting reported as inactive. The criterion names the indolent and non-contiguous phase of low grade NHL as a route to the total evaluation in its own right.

  • 03

    The date of discontinuance missing. Without it the two-year period has no start and the evaluation has no defined end.

  • 04

    An examination that reports remission without addressing recurrence. The note asks whether there has been recurrence and, if not, directs a rating on residuals.

Common filing mistakes4 tips
  • 01

    Accepting a reduction before two years have run from discontinuance of treatment. The note continues the 100 percent for that period by its own terms and makes the examination mandatory at the end of it.

  • 02

    Not claiming during watchful waiting. The indolent and non-contiguous phase of low grade NHL is one of the three stated routes to the 100 percent evaluation.

  • 03

    Filing the residuals under this code. They are rated under the codes for the body systems they affect, which is what the note directs.

  • 04

    Overlooking 38 CFR 3.105(e). The note applies it to any reduction based on the mandatory examination or a subsequent one.

When symptoms may first appear2 tips
  • 01

    The schedule states no course of onset for this code. Its criterion is written about a present state — active disease, a treatment phase, or an indolent and non-contiguous low-grade phase.

  • 02

    The interval the regulation fixes is two years, counted from discontinuance of treatment to a mandatory VA examination. It is the longest treatment-based protected period in § 4.117 and four times what the neighbouring malignancy codes provide.

LET’S CLEAR A FEW THINGS UP

Common questions about Non-Hodgkin's Lymphoma

Is Non-Hodgkin's Lymphoma a VA-rated disability?

Yes. The VA rates Non-Hodgkin's Lymphoma under VASRD diagnostic code 7715 (Hemic and Lymphatic Systems). DC 7715 states one evaluation, 100 percent, and reaches it three ways: active disease, a treatment phase, or the indolent and non-contiguous phase of low grade non-Hodgkin's lymphoma. That third route is the one most likely to be missed, because it assigns a total evaluation to a disease that is being watched rather than treated. The note sets the rest: the 100 percent continues beyond cessation of treatment, and TWO YEARS after that treatment is discontinued — not six months, as the other lymphoma and leukemia codes provide — a mandatory VA examination determines the evaluation. If there has been no recurrence, the rating moves to the residuals.

What VA disability rating can I get for Non-Hodgkin's Lymphoma?

Possible VA ratings for Non-Hodgkin's Lymphoma are 100%, 0%. The 0% level comes from 38 CFR 4.31, which assigns it wherever no compensable level is met. Examples: 100%: When there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL.

What evidence helps prove Non-Hodgkin's Lymphoma for VA disability?

Strong evidence for a Non-Hodgkin's Lymphoma claim includes: The date treatment was discontinued. The note continues the 100 percent beyond cessation of treatment and runs two years from that date to the mandatory VA examination; For a low-grade lymphoma under observation, a record stating that it is indolent and non-contiguous. That is a stated route to the 100 percent evaluation and it does not require treatment; The grade and stage of the lymphoma. The third alternative in the criterion is written about low grade NHL specifically, so the pathology report is what places a claim on it; Records of the residuals by body system, since the note rates on residuals under the appropriate diagnostic codes where there has been no recurrence.

Which DBQ is used for Non-Hodgkin's Lymphoma?

VA's Hematologic and Lymphatic Conditions, Including Leukemia Disability Benefits Questionnaire (DBQ) is on its public list of DBQs. VA's page says: "You can use these forms to submit medical evidence from your health care providers."

What mistakes should veterans avoid when claiming Non-Hodgkin's Lymphoma?

Common pitfalls when filing for Non-Hodgkin's Lymphoma: Accepting a reduction before two years have run from discontinuance of treatment. The note continues the 100 percent for that period by its own terms and makes the examination mandatory at the end of it; Not claiming during watchful waiting. The indolent and non-contiguous phase of low grade NHL is one of the three stated routes to the 100 percent evaluation; Filing the residuals under this code. They are rated under the codes for the body systems they affect, which is what the note directs; Overlooking 38 CFR 3.105(e). The note applies it to any reduction based on the mandatory examination or a subsequent one.

Is Non-Hodgkin's Lymphoma a presumptive condition for VA benefits?

Yes, for a veteran who meets a presumption's conditions. 38 CFR 3.309(e) names "Non-Hodgkin's lymphoma" among the diseases associated with herbicide agents, for a veteran exposed to one during service. The regulation presumes that exposure for service in Vietnam, including its offshore waters, from January 9, 1962 to May 7, 1975; in a unit that, as the Department of Defense determined, operated in or near the Korean DMZ where herbicides were applied, from April 1, 1968 to August 31, 1971; or, in the Air Force or Air Force Reserve, regularly and repeatedly aboard C-123 aircraft used to spray herbicides (38 CFR 3.307(a)(6)). The statute, 38 U.S.C. 1116, 1116A and 1116B, also covers U.S. or Royal Thai bases in Thailand, Laos, Mimot or Krek in Cambodia, Guam or American Samoa or their territorial waters, Johnston Atoll or a ship that called there, and the DMZ from September 1, 1967, each in its own period. 38 CFR 3.309(f) names "Non-Hodgkin's lymphoma" among the diseases associated with the water supply at Camp Lejeune, for a veteran, former reservist or member of the National Guard with at least 30 days of service in total, consecutive or not, at Camp Lejeune or Marine Corps Air Station New River between August 1, 1953 and December 31, 1987 (38 CFR 3.307(a)(7)). 38 CFR 3.309(d) names "Lymphomas (except Hodgkin's disease)" among the diseases specific to radiation-exposed veterans, whom 38 CFR 3.309(d)(3) defines by radiation-risk activity, such as onsite participation in an atmospheric nuclear test or the occupation of Hiroshima or Nagasaki from August 6, 1945 to July 1, 1946. 38 U.S.C. 1120(b) names "Lymphoma cancer of any type" for a covered veteran: one who, on or after August 2, 1990, was assigned to a duty station in, or in the airspace above, Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia or the United Arab Emirates, or, on or after September 11, 2001, Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen or Uzbekistan (38 U.S.C. 1119(c)). Each presumption gives way to affirmative evidence to the contrary (38 CFR 3.307(d); 38 U.S.C. 1113).

How long does the 100 percent for non-Hodgkin's lymphoma continue after treatment?

Two years, which is four times what the neighbouring codes give. DC 7715's note says the 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures, and that two years after discontinuance of such treatment the appropriate disability rating shall be determined by mandatory VA examination. DC 7709 (Hodgkin's lymphoma) and DC 7703 (leukemia) both use six months for the same sentence, so reading across from one of them understates this code by eighteen months. Any reduction based on that examination or a later one is subject to 38 CFR 3.105(e), and if there has been no recurrence the evaluation moves to the residuals under the appropriate diagnostic codes.

Can I be rated if my lymphoma is low grade and only being watched?

Yes - the criterion says so directly. DC 7715 assigns 100 percent "when there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL". That third alternative requires no treatment at all, which makes it the route most easily missed on a veteran under watchful waiting. The pathology report is what places a claim on it, because the criterion is written about low grade NHL specifically and about the disease being indolent and non-contiguous.

Official sources

  1. 38 CFR § 4.117, Schedule of ratings, hemic and lymphatic systems (Diagnostic Code 7715)
  2. 38 CFR § 4.31, zero percent evaluations
  3. 38 CFR 3.309(e), presumptive service connection
  4. 38 CFR 3.309(f), presumptive service connection
  5. 38 CFR 3.309(d), presumptive service connection
  6. 38 U.S.C. 1120(b), presumptive service connection

Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.

How these figures are checked: our methodology and the open dataset.

KEEP YOUR RESEARCH

Is Non-Hodgkin's Lymphoma one of your conditions?

Start a free claim-planning workspace. If Non-Hodgkin's Lymphoma is yours, you can add it to your list there and pick up where you left off. Nothing is added unless you choose it.

Add it to my free plan

PUT THE PIECES TOGETHER

What could your combined rating look like?

See how Non-Hodgkin's Lymphoma combines with your other service-connected conditions using the official VA combined-ratings formula.

Open the free calculator
VA Calc: Disability Pay app icon

VA Calc: Disability Pay

Combine your ratings & see monthly pay on your iPhone · Works offline

Download on theApp Store